GENETIC TARGETS OF NITRIC OXIDE IN LEUKEMIA CELLS
白血病细胞中一氧化氮的基因靶标
基本信息
- 批准号:6436675
- 负责人:
- 金额:$ 20.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-01 至 2005-06-30
- 项目状态:已结题
- 来源:
- 关键词:NOD mouse SCID mouse acute myelogenous leukemia apoptosis cell differentiation cell growth regulation clinical research complementary DNA fusion gene gene expression gene targeting green fluorescent proteins hematopoietic stem cells human tissue laboratory rabbit microarray technology nitric oxide nucleic acid sequence representational difference analysis tissue /cell culture transfection /expression vector
项目摘要
DESCRIPTION: (provided by applicant) Nitric oxide (NO) inhibits growth, induces
differentiation and apoptosis in acute myeloid leukemia (AML) cells. Using the
technique of Representational Difference Analysis of cDNA (RDA), I have
identified a novel gene that I have named regulated by nitric oxide or rno. rno
is upregulated by NO in AML cells and is expressed exclusively in hematopoietic
cells. A cDNA clone of rno was obtained from a normal leukocyte library. The
predicted sequence of rno shows that it belongs to the family of leucine rich
repeat proteins and has a high degree of homology to the human ribonuclease
inhibitor. PCR and sequencing also revealed that there are at least 3 isoforms
of rno. Expression of rno in AML cells inhibits growth, and induces
differentiation and apoptosis. The HYPOTHESIS for this proposal is that NO
affects the growth and differentiation of AML cells by modulating the
expression of specific genes. rno could be involved in mediating the effects of
NO on hematopoietic cells. The SPECIFIC AIMS are: AIM 1-Clone and sequence the
complete cDNA for rno isoforms: This will be done by screening a cDNA library
made from RNA obtained from normal human peripheral blood leukocytes. AIM
2-Demonstrate that rno affects the growth and differentiation of hematopoietic
cells. This will be accomplished by transfecting rno into HL-60 cells and
determining the effect of rno expression on cell growth and differentiation.
The subcellular distribution of rno will be determined using a rno Green
Fluorescent Protein fusion gene. rno will be expressed in E. coli and rno
protein will be purified to study its effects on RNAse function. Antisera to
rno will be raised for further functional studies. rno expression will be
determined in normal hematopoietic cells at different stages of
differentiation. AIM 3-Identify genes that are modulated by rno: rno will be
cloned in an expression vector with an inducible promoter. The vector will be
transfected into HL-60 cells. By using cDNA array technology, gene expression
differences between rno expressing and non-expressing cells will be identified.
AIM 4-Determine the effect of rno expression on AML cell growth in vivo. I will
use a human AML xenograft model in NOD/SCID mice. The animals will be
inoculated with HL-60 cells that have been transfected with an inducible rno
expression vector. Induction of rno expression in the leukemia cells in vivo
will be done by treatment of the animals with Tetracycline. The effect of rno
expression on leukemia cell growth in vivo will be determined.
This work will help understand the mechanism by which NO affects hematopoietic
cell growth and differentiation and may constitute the basis for the
development of novel strategies for the treatment of AML.
描述:(由申请人提供)一氧化氮(NO)抑制生长,诱导
急性髓性白血病(AML)细胞的分化和凋亡。使用
cDNA的代表性差异分析(RDA)技术,
我发现了一种新的基因,我命名为受一氧化氮或rno调控的基因。rno
在AML细胞中被NO上调,并且仅在造血细胞中表达。
细胞从正常白细胞文库中获得rno的cDNA克隆。的
预测的rno序列表明,它属于富含亮氨酸的家族,
重复蛋白,并与人核糖核酸酶具有高度同源性
抑制剂. PCR和测序也显示至少有3种异构体
的rno。rno在AML细胞中的表达抑制生长,并诱导
分化和凋亡。该提案的假设是,
影响AML细胞的生长和分化,
特定基因的表达。rno可能参与介导
对造血细胞无影响。具体目标是:AIM 1-克隆和测序
rno亚型的完整cDNA:这将通过筛选cDNA文库来完成
由正常人外周血白细胞中的RNA制成。目的
2-证明rno影响造血干细胞的生长和分化
细胞这将通过将rno转染到HL-60细胞中来实现,
确定RNO表达对细胞生长和分化的影响。
rno的亚细胞分布将使用rno绿色
荧光蛋白融合基因。rno将在E.大肠杆菌和rno
蛋白质将被纯化以研究其对RNA酶功能的影响。抗血清
将提出rno以进行进一步的功能研究。rno表达式将是
在不同阶段的正常造血细胞中测定,
分化目的3-识别由rno调节的基因:
克隆到具有诱导型启动子的表达载体中。矢量将是
转染HL-60细胞。利用cDNA阵列技术,
将鉴定rno表达细胞和非表达细胞之间的差异。
目的4-确定rno表达对体内AML细胞生长的影响。我会
在NOD/SCID小鼠中使用人AML异种移植物模型。将动物
接种已转染诱导型rno的HL-60细胞,
表达载体在体内诱导白血病细胞表达rno
将通过用四环素处理动物完成。rno的作用
将测定对体内白血病细胞生长的表达。
这项工作将有助于了解NO影响造血的机制
细胞的生长和分化,并可能构成的基础,
开发治疗AML的新策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul J Shami其他文献
Novel Data Analytics Identify Predictors of Quality-of-Life Trajectories in Patients with AML or High-Risk Myeloid Neoplasms
新颖的数据分析确定急性髓系白血病或高危髓系肿瘤患者生活质量轨迹的预测因子
- DOI:
10.1182/blood-2022-165437 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:23.100
- 作者:
Jordan Gauthier;Bianca Furtuna;Jacopo Mangiavacchi;Shahrzad Gholami;Juan Lavista Ferres;Rahul Dodhia;Amir T. Fathi;Andrew M. Brunner;Aaron T. Gerds;Mikkael A. Sekeres;Bruno C. Medeiros;Eunice S. Wang;Paul J Shami;Kehinde Adekola;Selina M. Luger;Maria R. Baer;David A Rizzieri;Tanya Wildes;Jamie L. Koprivnikar;Julie Smith;Mohamed L. Sorror - 通讯作者:
Mohamed L. Sorror
Development of a Comprehensive Program for Evaluation of Hereditary Predisposition to Hematologic Malignancies
- DOI:
10.1182/blood-2022-170000 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Jennie Vagher;Bryan D. Huber;Luke Maese;Archana M Agarwal;Afaf Osman;Ami B. Patel;Tsewang Tashi;Paul J Shami;Tibor Kovacsovics;Julie D. Asch;Charles J. Parker;Srinivas K. Tantravahi - 通讯作者:
Srinivas K. Tantravahi
Revumenib Monotherapy in Patients with Relapsed/Refractory emKMT2Ar/em Acute Leukemias: Efficacy and Safety Results from the Augment-101 Phase 1/2 Study
Revumenib 单药治疗复发/难治性 emKMT2Ar/em 急性白血病患者:Augment-101 期 1/2 研究的疗效和安全性结果
- DOI:
10.1182/blood-2023-189762 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:23.100
- 作者:
Ibrahim Aldoss;Ghayas C. Issa;Michael J Thirman;John DiPersio;Martha Arellano;James S. Blachly;Gabriel Mannis;Alexander Perl;David Dickens;Christine M. McMahon;Elie Traer;C. Michel Zwaan;Carolyn Grove;Richard Stone;Paul J Shami;Ioannis Mantzaris;Matthew Greenwood;Neerav Shukla;Branko Cuglievan;Yu Gu;Eytan M. Stein - 通讯作者:
Eytan M. Stein
Revumenib Monotherapy in Patients with Relapsed/Refractory <em>KMT2Ar</em> Acute Leukemias: Efficacy and Safety Results from the Augment-101 Phase 1/2 Study
- DOI:
10.1182/blood-2023-189762 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Ibrahim Aldoss;Ghayas C. Issa;Michael J Thirman;John DiPersio;Martha Arellano;James S. Blachly;Gabriel Mannis;Alexander Perl;David Dickens;Christine M. McMahon;Elie Traer;C. Michel Zwaan;Carolyn Grove;Richard Stone;Paul J Shami;Ioannis Mantzaris;Matthew Greenwood;Neerav Shukla;Branko Cuglievan;Yu Gu - 通讯作者:
Yu Gu
Paul J Shami的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul J Shami', 18)}}的其他基金
Development of JS-K as an anti-leukemic agent
JS-K作为抗白血病药物的开发
- 批准号:
7811151 - 财政年份:2009
- 资助金额:
$ 20.78万 - 项目类别:
Development of JS-K as an anti-leukemic agent
JS-K作为抗白血病药物的开发
- 批准号:
8025951 - 财政年份:2008
- 资助金额:
$ 20.78万 - 项目类别:
Development of JS-K as an anti-leukemic agent
JS-K作为抗白血病药物的开发
- 批准号:
7759546 - 财政年份:2008
- 资助金额:
$ 20.78万 - 项目类别:
Development of JS-K as an anti-leukemic agent
JS-K作为抗白血病药物的开发
- 批准号:
7465286 - 财政年份:2008
- 资助金额:
$ 20.78万 - 项目类别:
Development of JS-K as an anti-leukemic agent
JS-K作为抗白血病药物的开发
- 批准号:
7582327 - 财政年份:2008
- 资助金额:
$ 20.78万 - 项目类别:
Development of JS-K as an anti-leukemic agent
JS-K作为抗白血病药物的开发
- 批准号:
8205033 - 财政年份:2008
- 资助金额:
$ 20.78万 - 项目类别:
ROLE OF NITRIC OXIDE IN MYELODYSPLASTIC SYNDROMES
一氧化氮在骨髓增生异常综合征中的作用
- 批准号:
7201437 - 财政年份:2005
- 资助金额:
$ 20.78万 - 项目类别:
GENETIC TARGETS OF NITRIC OXIDE IN LEUKEMIA CELLS
白血病细胞中一氧化氮的基因靶点
- 批准号:
6763232 - 财政年份:2002
- 资助金额:
$ 20.78万 - 项目类别:
GENETIC TARGETS OF NITRIC OXIDE IN LEUKEMIA CELLS
白血病细胞中一氧化氮的基因靶点
- 批准号:
6621777 - 财政年份:2002
- 资助金额:
$ 20.78万 - 项目类别:
NO, GUANYLATE CYCLASE AND IMMUNOTHERAPY OF CANCER
不,鸟苷酸环化酶与癌症免疫治疗
- 批准号:
6129929 - 财政年份:2000
- 资助金额:
$ 20.78万 - 项目类别:
相似海外基金
Analysis of transmembrane proteins activity in urological cancers using humanized SCID mouse
使用人源化 SCID 小鼠分析泌尿系统癌症中的跨膜蛋白活性
- 批准号:
19K09674 - 财政年份:2019
- 资助金额:
$ 20.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Core B - SCID Mouse : Human Xenograft Core (Jordan Pober, MD/PhDP.I.)
核心 B - SCID 小鼠:人类异种移植核心(Jordan Pober,医学博士/博士)
- 批准号:
6756347 - 财政年份:2004
- 资助金额:
$ 20.78万 - 项目类别:
EXPERIMENTAL ANALYSIS OF VASCULER CHANGES IN CHRONIC ALLOGRAFT REJECTION USING HUMANIZED SCID MOUSE MODEL.
使用人源化 SCID 小鼠模型对慢性同种异体移植排斥中的血管变化进行实验分析。
- 批准号:
14571526 - 财政年份:2002
- 资助金额:
$ 20.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The heat shock protein(HSP) was investigated as the pathogenesis of focal infection with tonsil by the SCID mouse model
通过SCID小鼠模型研究热休克蛋白(HSP)作为扁桃体局灶性感染的发病机制
- 批准号:
14571629 - 财政年份:2002
- 资助金额:
$ 20.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of patient-like SCID mouse model by orthotopically implanting primary cultured cells from surgically-resected lung cancer tissues.
通过原位植入手术切除的肺癌组织的原代培养细胞建立类患者 SCID 小鼠模型。
- 批准号:
14571269 - 财政年份:2002
- 资助金额:
$ 20.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)